BEAM

NASD Beam Therapeutics, Inc.
Oct 5, 2026 · 9:16 AM ET LAST TRADE Market Closed

$24.36 ↓ -0.14 (-0.57%) Trading Down from the previous close of $24.50

YTD change
-12.12%
vs 20-day SMA
-1.91%
vs 200-day SMA
-14.45%

Price ranges

Previous day
$24.21 $25.48
open $25.00 close $24.50
-$0.50 (-2.00%)
Today
$0.00 $0.00
$24.36
Past week
$23.44 $25.48
from $24.27 now $24.36
+$0.09 (+0.37%)
Past month
$22.67 $29.97
from $29.46 now $24.36
-$5.10 (-17.31%)
This year
$21.63 $38.26
from $27.72 now $24.36
-$3.36 (-12.12%)

Price & Performance

+0.27 (+1.11%) / 6M

$21.91$27.64$33.38$39.11Apr 6Jul 6Oct 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 82.4% away from all-time highs of $138.52
  • BEAM is down 12% since the beginning of the year
  • BEAM is down 5% over the past 12 months
  • BEAM is down 17% over the past 1 month
  • 27% of all BEAM investors are betting against BEAM

BEAM reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -5.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.18
Earnings momentum -2.3% Quarterly EPS growth
Quarterly change -2.3%

Valuation

P/E ratio N/A
Enterprise value $1.7B
Beta 3.36

Balance sheet & scale

IncomeN/A
Revenue$156.0M
Cash$1.2B
Debt$247.4K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $2.5B

Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201. The company was founded by David R. Liu, Feng Zhang, Alexis Komor, Nicole Gaudelli, and J. Keith Joung on January 25, 2017 and is headquartered in Cambridge, MA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $403.04 -1.04%
MRNA Moderna, Inc. $190.01 +0.57%
RVMD Revolution Medicines, Inc. $206.64 +0.36%
ROIV Roivant Sciences Ltd. $35.72 +0.62%
BNTX BioNTech SE Sponsored ADR $96.90 +0.05%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.